< 103 IU/ml | 103–106 U/ml | > 106 IU/ml | |
---|---|---|---|
Subjects (n) | 55 | 46 | 92 |
Gestational age (weeks) | 36.65 ± 2.15 | 36.00 ± 3.00 | 35.66 ± 2.69a |
Peak TBA level (µmol/L) | 41.5(28.05–61.85) | 53.4(30.63–115.03) | 67.3(44–108.8)a |
ALT (U/L) | 16(10.5–21.5) | 59.5(19–402.98)a | 198(56–517)a |
AST (U/L) | 20(16–27.5) | 50.5(23.5–365)a | 181(41–430)a |
TBIL (µmol/L) | 6.8(4.65–8.85) | 10.05(6.1–17.6)a | 10.4(7.15–45.45)a |
Preterm birth (n%) | 15(27.3%) | 22(47.8%)a | 53(57.6%)a |
MSAF (n%) | 9(16.4%) | 13(28.3%) | 27(29.3%)a |
Birth weight (g) | 2795.42 ± 491.67 | 2787.73 ± 468.78 | 2600.94 ± 531.78a |
Birth height (cm) | 47.40 ± 3.36 | 47.16 ± 3.24 | 46.17 ± 3.28a |
Apgar score (1 min) | 9.92 ± 0.34 | 9.75 ± 0.611 | 9.64 ± 1.51 |
Admitted to the NICU (n%) | 24(43.6%) | 27(58.7%)a | 62(67.4%)ab |
Intrauterine death (n%) | 1(1.8%) | 0 | 2(2.2%) |